<?xml version="1.0" encoding="UTF-8"?>
<p id="para270">
 <ext-link ext-link-type="uri" xlink:href="https://www.jhsph.edu/faculty/directory/profile/3126/arturo-casadevall" id="interrefs220" xmlns:xlink="http://www.w3.org/1999/xlink">Arturo Casadevall</ext-link> at the Johns Hopkins School of Public Health in Maryland says that the antibodies in the serum sop up viruses much like how a sponge sucks up a spill. He is now ramping up a four-site clinical trial to evaluate the strategy within weeks. He also envisions a coronavirus-specific plasma bank in which recovering individuals can provide antibodies to those who are still ailing, something he says could be off the ground in a few months. “One survivor can donate enough plasma to help two sick people,” he says.
</p>
